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SUMMARY 
 
Background: The insertion of external ventricular drains (EVD) is necessary in some 
neurosurgical patients but increases the risk of meningitis/ventriculitis. While there are well 
recognised risk factors, the proportion of patients developing meningitis/ventriculitis varies 
partly due to differences in definitions.  A multi-disciplinary working group was established 
to agree definitions for EVD-associated meningitis/ventriculitis and a surveillance system 
was piloted in four centres in the UK and Ireland. 
Methods: Definitions were agreed based on those previously published and on clinical and 
microbiological criteria. An agreed dataset was developed to monitor patients after the 
insertion of an EVD and until the EVD was removed.  Risk factors and the microbial 
aetiology were recorded. 
Findings: Four neurosurgical centres participated with between 61 and 564 patients being 
surveyed in each unit. The vast majority of drains were cranial. Intra-cranial haemorrhage 
was the most common indication for the EVD insertion. Between 6 and 35% were inserted by 
consultants compared to junior doctors. The proportion developing meningitis/ventriculitis 
varied from 3-18% and from 4.8-12.7/1000 EVD days.  Coagulase negative staphylococci 
were the most common microbial causes.  
Conclusions: The routine and on-going monitoring of patients with an EVD in situ to detect 
meningitis/ventriculitis presents logistical difficulties and few units undertake this. We 
believe that a national system of surveillance with agreed definitions and a methodology to 
enable unit-to-unit comparisons of EVD meningitis/ventriculitis, based on this pilot study, is 
both needed and feasible.  This will in turn inform quality improvement processes leading to 
the minimisation of infection.  
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Introduction 
Patients undergoing neurosurgery are at increased risk of healthcare-associated infections 
(HCAI).  In the 2006 four - country prevalence survey of HCAI, the prevalence rate in 
neurosurgery was 10.5%.1 Incidence studies of neurosurgical units in Italy and Germany 
found that meningitis occurred in 4-8% of patients.2,3  Post-operative meningitis/ventriculitis 
is particularly a risk when an external ventricular drain (EVD) is inserted to monitor or 
control intracranial pressure.  
 
Beer and colleagues conducted a Medline literature search of ventriculitis/meningitis and the 
rate of infection varied from 5 to 20%.4 This wide variation may relate to the diagnostic 
criteria used.  Amongst the risk factors they identified were: the duration of EVD, the 
frequency of EVD manipulations, the presence of intra-ventricular haemorrhage and the 
surgical technique used in inserting the device; the rate is lower when the device is tunnelled 
under the skin after exit from the cranium with skin puncture distally from this.4  A 
retrospective cohort study using data from national surveillance in the Netherlands was used 
to develop prediction models that would assist in the detection of EVD-related meningitis.5  
Observed and predicted rates of infection were compared and the correlation was 
approximately 95% between both.   Predictive factors for meningitis were abnormalities of 
the CSF such as raised white cell count, the type of drain (ventricular or lumbar), and 
whether admission to an intensive care unit was required.5 
 
A wide variety of criteria to diagnose meningitis/ventriculitis are used, some of which are 
exclusively microbiologically based, i.e. a positive CSF culture, while others include 
microbiology findings, clinical presenting features and CSF abnormalities such as increased 
CSF leukocyte count.6 For surveillance purposes, it is preferable not to include a decision to 
treat with antibiotics because meningitis/ventriculitis may be mimicked by other conditions, 
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e.g. intra-cranial haemorrhage, and antibiotics may be given to treat  infection at other sites in 
a seriously ill patient.  A further challenge for surveillance is selecting an appropriate 
denominator.  Rates of infection are often calculated as numbers of patients with infection as 
a percentage of the total with an EVD.  However, the use of denominators that account for 
the duration of the device are preferable, e.g. per 1,000 EVD days as the risk of infection 
increases the longer the EVD is in situ.   
 
Most causes of meningitis/ventriculitis are skin organisms and therefore staphylococci, i.e. 
Staphylococcus epidermidis and S. aureus, account for nearly 80% followed by a variety of 
other organisms that include aerobic Gram negative bacilli (AGNB) and occasionally fungi.4  
The isolation of S. epidermidis or other coagulase negative staphylococci (CoNS) in the CSF 
needs to be interpreted with caution as this may represent contamination and can result in 
over-treatment.   
 
In the absence of a national surveillance system of neurosurgical meningitis/ventricultis, a 
multi-disciplinary working party was established and funded under the auspices of the 
Healthcare Infection Society to: agree definitions, identify the challenges in establishing a 
national surveillance system and highlight preventative strategies.  The purpose was to test 
the feasibility and practicality of a surveillance system to measure the incidence of 
ventriculitis associated with EVD in neurosurgical patients. Here we report on the agreed 
definitions and their use, a suggested dataset, and the results from a multi-centre UK and 
Ireland pilot surveillance system.   
 
Methods 
While the insertion of an EVD is a surgical procedure, the device provides an external route 
by which pathogens may gain access to the ventricles.  The risk of infection is therefore 
likely to be influenced by the length of time that the device remains in situ and the extent to 
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which it is manipulated during this period, rather than specifically to the insertion procedure.  
The methodology developed for this surveillance was therefore based on the methods used 
for central vascular catheters, rather than surgical site infection, and used device days as a 
primary denominator to calculate the risk of EVD-associated ventriculitis.7,8  The data 
captured were used to calculate the following metrics: 
 Rate of ventriculitis/1000 EVD days  
 Percentage of patients with EVD who developed ventriculitis 
The number of EVD days was determined as the days between device insertion and device 
removal for all patients included in surveillance.   
 
A patient-level surveillance method was employed and each patient with a newly inserted 
drain was followed prospectively to identify if ventriculitis occurred.9  Table I indicates the 
variables captured for each patient included in the surveillance.  Surveillance was continued 
until the device was removed or the patient was transferred/discharged or died.   
 
The case definitions for EVD-associated ventriculitis were developed after much discussion 
and consideration of existing published ones, and were adapted from Horan et al 2008, to 
distinguish probable from definite meningitis/ventriculitis (Table II).10  Cases of ventriculitis 
clearly associated with a recently removed EVD were included, and if an EVD was replaced 
this was considered as a new device and a new surveillance record commenced. A new 
episode of infection was recorded if a different microorganism was isolated from the CSF or 
the same microorganism was isolated from the CSF but at least 4 weeks had elapsed from a 
previous infection and there was evidence that the first infection had resolved.11 When 
definite or probable venticulitis met the definition, the causative pathogen was recorded.  
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Local policies and demographic data 
Local policies for the insertion and management of EVD vary.  Data were therefore captured 
from units participating in the surveillance related to local policies on the type of EVD used, 
whether devices were tunnelled, type of dressing, and protocols for sampling, manipulation 
and replacement of EVDs. For each EVD included in the surveillance, a set of patient data 
(age, gender, BMI) and device data were captured (see Table I).  If the EVD was manipulated 
the date and reason for manipulation were recorded. 
 
Data collection 
Data were collected locally by medical microbiologists, neurosurgeons or other clinical staff 
by prospective surveillance of all patients who had an EVD inserted during the study period, 
using a standard protocol. 
 
Ethics 
Since this study comprised the capture of routinely available data for the purpose of 
surveillance of infection, ethical approval was not required.    
 
Results 
Four centres participated in the pilot surveillance project ranging in size from a unit 
performing 1063 procedures a year (unit 1) to the largest unit which performed 2643 
procedures annually (unit 2).  In all of the units (Table III), EVDs were tunnelled.  There was 
variation in the frequency of CSF sampling between the unit even if it is was mainly carried 
out as clinically indicated.  However, in one unit, it also varied according to the individual 
consultant neurosurgeon.  Likewise, data captured in the unit questionnaire demonstrated 
variations in unit protocols for the frequency of EVD manipulation from less than once a 
week in unit 2 to weekly and one or more times per week in unit 1 (Table III). We were not 
able to reliably record the reasons for EVD manipulation during prospective data capture. 
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The number of patients that were surveyed varied from 61 in unit 3 to 564 in unit 4 where 
there was an ongoing programme of surveillance of infection following the insertion of 
EVDs.  Also, some patients had more than one EVD inserted due to the need to remove and 
replace an EVD because of blockage. The duration of EVDs in-situ varied (Table IV) from 5 
days or less to greater than 10 days.  The vast majority of drains were inserted cranially.  In 
unit 3 only cranial EVDs were surveyed.  Antibiotic-impregnated devices accounted for 
73.7% (660/895) EVDs whilst silver coated EVDs were used in only two units and accounted 
for 0.44% (4/895).  However, two units (1 and 4) frequently used both standard and 
antibiotic-impregnated devices.   
 
The main indications for the insertion of the EVD were haemorrhage (47.3% 473/895) 
followed by tumour (21.6% 193/895).  A minority of EVDs were inserted by consultants 
(21%, range 6%-35%). A total of 45 patients with an EVD developed an infection, a rate of 
5.02%, ranging from 3% in unit 4 to 18% in unit 1. The latter unit also appeared to perform 
the most manipulations of EVDs.   The rates per 1,000 EVD days were: 12.7 in unit1, 5.17 in 
unit 2, 4.8 in unit 3 and 5.9 in unit 4. The median duration of EVD use for patients with an 
infection compared to those without was: 19 versus 10 days in unit 2, 9.6 versus 13.67 days 
in unit 3 and 10.5 versus 2 days in unit 4.  The corresponding data for unit 1 were not 
available.  All nine infections in unit 1 were definite, seven of eight were definite in unit 2 
with one probable, all three infections in unit 3 were definite and finally, the 17 EVD 
infections in unit 4 were not categorised as either definite or probable. A total of 47 isolates 
from EVD infections were recorded.  Of these, 24 (52.2%) were S. epidermidis  and 16 
(37.8%) were AGNB.  
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Discussion 
 
This pilot study was designed to look at the feasibility of the ongoing collection of data 
following the insertion of EVDs in neurosurgical units.  Currently, this occurs in only a 
minority of units.  The working group spent a considerable amount of time reviewing 
previously published definitions and then drafted ones for use in this pilot study that were felt 
to be robust for routine use.  In particular, we did not allow for the inclusion of a decision to 
start antibiotics empirically for the treatment of meningitis/ventriculitis as a criterion for 
definite or probable infection.   
 
The data were collected by whoever was available in each particular unit. However, the 
number of units involved, the number of patients surveyed and the details collected were less 
than had originally been intended indicating the resources necessary for on-going 
surveillance of these patients. Any future national surveillance system would need to provide 
guidance on logistics such as when and who is best positioned to collect data, how it will be 
analysed and shared, and what actions will ensue. For many units, this would need some 
additional resources to ensure the regular and comprehensive collection of data. 
 
Not unexpectedly, there were variations in practice between the units such as how often 
EVDs were manipulated and the type of EVD used, i.e. standard, silver- or antibiotic-
impregnated catheters.  Despite using defined criteria to identify infections, the proportion of 
patients with meningitis/ventriculitis associated with an EVD varied between units from 3% 
to 18% and from 4.8-12.7/1,000 EVD days, although the type of microbes responsible was 
largely similar throughout. 
 
Ventriculitis/meningitis following EVD insertion is a relatively common healthcare-acquired 
infection in neurosurgical patients if less prevalent than respiratory tract, urinary tract and 
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bloodstream infections.12-14  A variety of recent studies reveal a variation in the proportion of 
patients with meningitis/ventriculitis after EVD insertion and also the actual incidence per 
1,000 catheter-days.  In a study from New York of 343 patients, the proportion of patients 
developing ventriculitis was 3.5% and 10/12 patients with positive CSF cultures also had 
infections elsewhere.  The most common pathogens associated with EVD infection were 
mainly skin flora and in terms of risk factors patients developing ventriculitis were more 
likely to have a prolonged duration of EVD in-situ.15 In a Brazilian study of 119 patients, the 
proportion of patients developing infection was 18.3% or 22.4 per 1000 catheter days but the 
majority of infections were due to AGNB.16 
   
Many of the studies reported in the literature are limited by being single centre studies or 
involving relatively small numbers of patients.  There are logistical difficulties in conducting 
multi-site studies and in collecting data over a prolonged period of time unless adequate 
resources are in place, as our study also highlights.  However, in an Italian study of 13 ICUs 
where each unit recruited 10 or more patients over a period of 6 months or more, data were 
collated on 271 patients involving a total of 311 catheters.17   Fifteen patients (5.5%) had 
confirmed ventriculitis/meningitis and 15 patients (5.5%) had suspected infection.  Gram-
negative bacteria were equally as likely to be the cause of infection as Gram positive bacteria 
and risk factors for infection included placement of the EVD outside the operating room, a 
co-existing extra-cranial infection and a combination of both an EVD and a lumbar drain in-
situ.17 This study included more sites than ours but collected data on fewer patients.  
Nonetheless, the overall proportion of patients with meningitis/ventriculitis was similar even 
if there were fewer infections due to AGNB in our study. The British Neurosurgical Trainee 
Research Collaborative (BNTRC) is in the process of completing a multicentre audit of 
EVDs throughout the UK and Ireland, including rates of infection but using different 
definitions, and the results from this may further inform ongoing surveillance systems and 
how they can best be delivered.   
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The collection of local data and its comparison with other centres facilitates the identification 
of those factors which may be contributing to infection and what measures are necessary to 
manage infection.  This requires agreed definitions for infection.  We reviewed those already 
available and decided on the ones above because we believe they are feasible and allow for 
the variables involved.  Unlike those from the Centre for Disease Prevention and Control and 
the National Healthcare Safety Network in the USA, we had two categories, i.e. definite and 
probable, and our definitions require two culture positive CSFs for microbes that can colonise 
the skin to be deemed probable meningitis.  Also, we do not specifically include  
meningitis/ventriculitis in the newborn in our pilot study.18  
 
As with measures to reduce bloodstream infection and ventilator-associated pneumonia, there 
is increasing use of a healthcare bundle to minimise EVD-associated infection.  A bundle 
consisting of education, meticulous EVD handling, CSF sampling only when clinically 
necessary and the routine replacement of the EVD on the 7th day was instituted in an ICU in 
Greece.19   This resulted in a fall in the proportion of patients infected from 28% to 10.5% 
with Acinetobacter baumannii being the most common cause.  In another study of 2928 
EVDs inserted over a six year period, a comprehensive protocol or bundle for EVD 
placement was developed and its efficacy evaluated.20   The protocol included the use of pre-
operative prophylactic antibiotics, use of antimicrobial catheters, and CSF sampling only 
when infection was suspected.  Following the implementation of the bundle, the proportion of 
patients infected fell from 1.5% to 0.46% with the highest incidence being between days 4-14 
after EVD insertion.  Gram positive bacteria such as CoNS were more common than Gram 
negative bacilli as the cause of infection.20   In a Dutch study where a very high baseline 
proportion of patients were infected, i.e. 37%, a comprehensive bundle was aggressively 
implemented between 2004 and 2006.  This included measures to reduce infection following 
the insertion of both EVDs and lumbar drains.21  This led to a statistically significant fall in 
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the infection rate to 11.3% but even after the intervention, the proportion of patients receiving 
antibiotic prophylaxis at the time of EVD insertion had increased only from 31% to 56%.20  
One of the possible reasons for the relatively high background rate of EVD-associated 
infections in this centre was that catheters were often inserted at the bedside but this was 
changed to having them inserted in a separate room dedicated for this procedure. 
 
There is clearly significant variation in the proportion of patients developing infection and the 
rate per thousand catheter days, as well as the causative organisms between some studies and 
for reasons that are not always obvious.  Nonetheless, the collection of data, its analysis and 
comparison with similar units is useful in identifying where improvements can be made.  As 
these are difficult to treat infections, sometimes causing death but often causing prolonged 
length of hospital stay and impaired intellectual capacity in some patients, there is a 
significant clinical need to improve practice and to improve the safety of patient care.  
 
Practice varies in terms of using standard, antibiotic or silver-impregnated EVDs; two of the 
four units did not use standard EVDs.  A recent meta-analysis of the impact of silver-
impregnated EVDs found only one randomised controlled trial (RCT) and six prospective or 
retrospective non-RCTs.22 There was a significantly lower infection rate associated with the 
silver-impregnated EVD in the RCT but not in the pooled non-RCTs. However, infections 
caused by Gram positive bacteria were lower in patients with silver-impregnated EVDs.  In a 
recent post-hoc analysis from the Netherlands involving two units, with plain EVDs and 
those coated with rifampicin and clindamycin, there was no significant difference in the rate 
of EVD-associated infection using both CDC and culture-based definitions.23  However, 
many studies in this clinical area are hampered by insufficient numbers of patients or by 
flawed design. Data from comprehensive surveillance performed at national level might 
indicate whether silver- or antibiotic-impregnated EVDs should be routinely used or only 
after other infection prevention measures have failed to reduce infection rates.  
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The purpose of our pilot study was to investigate the feasibility of on-going surveillance in 
neurosurgical units of infective complications following the insertion of EVDs with a view 
that such a system or a variation of it could be implemented nationally with an acceptable 
protocol.   Furthermore, not all aspects of infection prevention were surveyed such as the use 
of antibiotic prophylaxis and whether antibiotics were administered before insertion and or 
throughout the duration of EVD placement. However, the study was not large enough to 
make recommendations on preventative measures, one of the original objectives of the 
working group. As a pilot study, the study has limitations including being able to collect data 
from only four neurosurgical units and deficiencies in the data collected, e.g. one centre did 
not distinguish between definite and probable cases.  Also, the number of patients varied 
between the units as did practice such as the type of EVD used.  We were not able to 
investigate risk factors for infection given the lower number of units involved than had been 
expected.  However, the study emphasises the need for regular and comprehensive 
surveillance of patients at the time of EVD insertion until removal using agreed and robust 
definitions to help explain differences in infection rates and microbial aetiology. The data 
collected and the difference in the proportion of patients infected, highlights the need for on-
going surveillance, the sharing of data with comparisons allowing for differences in case-mix 
and ultimately the identification of factors which can be modified to reduce infection.   
 
In conclusions, we believe that the results of this pilot study and the BNTRC study confirm 
the need for and the feasibility of a national surveillance programme which would require 
some support locally. The use of an agreed set of definitions, a practical dataset and the 
sharing of data would identify risk factors, increase awareness and subsequently lead to the 
development of a set of guidelines, all contributing to reducing these important infections. 
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Table I. Denominator data variables collected during pilot study of external drain-related 
meningitis/ventriculitis  
 
Data item Options Data collection 
Patient demographics Age; gender; BMI; underlying disease On insertion 
Site of insertion Cranial; lumbar On insertion 
Date of insertion  On insertion 
Reason for EVD Intracranial haemorrhage; tumour; 
blocked ventriculo-peritoneal shunt; 
trauma; other 
On insertion 
Type of EVD Standard; silver coated; 
antimicrobial/other 
On insertion 
Tunnelled Yes; no On insertion 
Emergency Yes; no On insertion 
Surgeon Consultant; junior doctor On insertion 
ASA score 1 to 5/unknown On insertion 
EVD access Date and reason (CSF; drugs; other) Duration of 
EVD 
Reason surveillance 
discontinued 
EVD removed; EVD removed & 
replaced; patient transferred; patient 
discharged; patient died 
On completion 
of surveillance 
Date surveillance discontinued  On completion 
of surveillance 
 
BMI, body mass index; EVD, external ventricular drain; ASA- America Society of 
Anaesthesiology; CSF, cerebrospinal fluid 
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Table II. Definition of meningitis/ventriculitis used 
 
1. Definite post-operative bacterial meningitis/ventriculitis 
The patient needs to meet either of the following criteria based on positive culture 
results: 
A The isolation of a recognised pathogen, e.g. Staphylococcus aureus, Gram negative 
bacilli or yeasts from at least one CSF sample 
B  The isolation of the same coagulase negative staphylococcus, diphtheroid or other 
skin organism from two or more CSF specimens. 
 
2. Probable post-operative bacterial meningitis/ventriculitis 
The patient needs to meet at least two of the following criteria: - 
A Positive culture/ microscopic results:  
 The isolation of a potential skin isolate, e.g. coagulase negative staphylococci 
from only one CSF, OR 
 the isolation of bacteria/yeast from the tip of an indwelling neurosurgical 
device, e.g. EVD, or a positive CSF Gram stain in the absence of positive 
culture. 
B Clinical features: One or more of the following, fever, change in consciousness, new 
onset of seizures, signs of meningeal irritation 
C CSF inflammation: Raised or increasing white cell count or low CSF glucose, i.e. 
CSF: blood ratio of <60% 
CSF, cerebrospinal fluid; EVD, external ventricular drain. 
Note: A new episode of infection was recorded if a) a different microorganism is isolated 
from the CSF or b) the same microorganism was isolated from the CSF but at least 4 weeks 
had elapsed from the previous infection and there was clear evidence that the symptoms of 
the first infection had resolved e.g. higher Glasgow Coma Scale, reduced white cell count by 
>50%, and the eradication of the organisms on Gram stain and culture in one or more follow-
up CSF specimens, if the EVD remained in place. 
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Table III. General details of neurosurgical units involved in pilot surveillance project 
 
 Unit 1 Unit 2 Unit3 
 
Unit 4 
 
No. of 
neurosurgical 
procedures/year 
 
1063 
 
2643 
 
2493 
 
2274 
 
No. of EVDs 
inserted/year 
 
   82 
 
  131 
 
   90 
 
  74 
 
Whether EVDs are 
tunnelled or not 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Sampling protocol 
 
*Daily and as 
clinically 
required 
 
As clinically 
indicated 
 
As clinically 
indicated 
 
As clinically 
indicated 
 
Frequency of EVD 
manipulation 
 
 
≥ 1/week 
 
< 1/week 
 
Weekly 
 
Weekly 
*varied according to consultant 
EVD, external ventricular drain 
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Table IV. Data collect on external ventricular drain-associated ventriculitis in four 
neurosurgical unitso 
 Unit 1 Unit 2 Unit 3 Unit 4 
 
No. of patients 
surveyed 
 
82+ 
 
131 
 
 61 
 
564 
 
Duration of EVD in-
situ 
  
 
  
    ≤ 5 days            39 
(26%)                
         36 
(26%) 
16 (20%) 348 (62%) 
    6-9 days          71 
(47%) 
         23 
(16%) 
41 (51%)  99 (17%)  
    ≥ 10 days          40 
(27%) 
         82 
(58%)  
23 (29%) 117 (21%) 
 
Site of insertion 
 
 
   
    Cranial 80 129 61 515 
    Lumbar  7    2 - *  49 
 
Type of EVD 
    
   Standard  10   0  0 209 
   Silver-coated    0   0 2    2 
   Antimicrobial-
impregnated 
127 131 49 353 
   Other    2    0 10    0 
 
Indication for EVD 
    
   Haemorrhage 43 (41%) 66 (55%)  26 (43%) 370 (66%)  
   Tumour 40 (38%)  17 (14%) 11 (18%) 125 (22%)  
   Blocked shunt 12 (12%)   8 (7%)   0   13 (2%)  
   Trauma  8 (8%)   2 (2%)  1 (2%) 53 (9%) 
   Other  1 (1%) 27 (22%)  23 (37%)   3 (1)%) 
 
Status of operator 
 
 
 
 
 
 
 
 
  Consultant  8  (6%) 25 (19%) 14 (24%) 202 (35%) 
  Junior doctor 123 (94%) 106 (81%)  43 (76%)  362 (65%) 
   
Frequency of EVD 
    
  access     
  ≤ 5 times            36 
(60%) 
             124 
(95%) 
              57 
(92%) 
N/A 
  6-9 times            19 
(32%) 
                 6 
(4%) 
                4 
(6%)  
N/A 
  ≥ 10 times 
 
             5 
(8%) 
                 1 
(1%) 
                1 
(2%) 
N/A 
No. (%) of infections    17 (18%)             8 (6%)                3 
(5%) 
17 (3%) 
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Rate/1,000 EVD days 
 
Microbiology 
aetiology ** 
 
   12.7 
      
            5.17 
 
               4.8 
 
           5.9 
 CoNS            10                   3                  3             8 
 S. aureus              1                  0                  0             1 
 AGNB              4                  4                  0             4 
 yeasts              1                  0                  0             1 
 others              1                  1                    0              1 
 oFor some of the data, the denominator is number of patients and for others it is the number 
of EVDs; some patients had more than one EVD. 
EVD, external ventricular drain; CoNS, coagulase negative staphylococci; AGNB, aerobic 
Gram negative bacilli, N/A - not available 
* only cranial drains surveyed 
** for some infections ≥ 1 isolate was recovered 
 
 
